4 recruiting, 1 completed. 2 Phase 1, 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Recruiting 1 |
| Phase 2 | 2 | Recruiting 2 |
| Phase 3 | 1 | Recruiting 1 |
Follow Soquelitinib: new trials by email Literature Review of Soquelitinib trials Research Report on Soquelitinib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Soquelitinib in Adults With Hidradenitis Suppurativa Soquelitinib - Hidradenitis Suppurativa (HS) | Phase 1 | Recruiting | Corvus Pharmaceuticals, Inc. | 25 | 2026-09-17 | 2026-10-15 |
| Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD Soquelitinib, Placebo - Atopic Dermatitis, Atopic Dermatitis Eczema | Phase 2 | Recruiting | Corvus Pharmaceuticals, Inc. | 200 | 2026-02-01 | 2026-03-05 |
| Study of the ITK Inhibitor Soquelitinib to Reduce Lymphoproliferation and Improve Cytopenias in Autoimmune Lymphoproliferative Syndrome (ALPS)-FAS Patients Soquelitinib - Autoimmune Lymphoproliferative Syndrome | Phase 2 | Recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 15 | 2025-03-10 | 2026-09-08 |
| Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma Soquelitinib, Belinostat, Pralatrexate - Peripheral T-Cell Lymphoma, Not Otherwise Specified, Angioimmunoblastic T-cell Lymphoma | Phase 3 | Recruiting | Corvus Pharmaceuticals, Inc. | 150 | 2024-10-02 | 2026-09-25 |
| Safety, Tolerability, and Preliminary Efficacy of Soquelitinib in Participants With Moderate to Severe AD Soquelitinib, Placebo - Atopic Dermatitis | Phase 1 | Completed | Corvus Pharmaceuticals, Inc. | 82 | 2024-04-16 | 2026-03-12 |
Dermatitis, Atopic (2) · Autoimmune Lymphoproliferative Syndrome (1) · Autoimmune Lymphoproliferative Syndrome, Type IA (1) · Eczema (1) · Hidradenitis Suppurativa (1) · Hypersplenism (1) · Immunoblastic Lymphadenopathy (1) · Lymphoma, Large-Cell, Anaplastic (1) · Lymphoma, T-Cell (1) · Lymphoma, T-Cell, Peripheral (1)
Corvus Pharmaceuticals, Inc. (4) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (5) · Australia (1) · Canada (1)
Isin Sinem Bagci, MD (2) · Suresh Mahabhashyam, MD (1) · Suresh Mahabhashyam, MD, MPH (1) · V. Koneti Rao, M.D. (1)